The Latest Cardiac and Vascular News
Acarix continues the US expansion with another commercial partnership now covering Louisiana and parts of Mississippi. This partnership with Bio-Rhythms Inc provides access to cardiology clinics, emergency departments and primary care clinics in geographic areas with high medical need for rapid and cost-effective rule-out of coronary artery disease. Louisiana is among the top 5 US states based on […]
The US Food and Drug Administration has registered Qpatch, an ECG wearable unit developed by experts from Medicalgorithmics. The FDA approval allows use of ECG readings from Qpatch in the United States. WARSAW, Poland, June 9, 2022 /PRNewswire/ — Qpatch is a state-of-the-art wearable device for measuring individual ECG signal to obtain accurate […]
Existing investor syndicate supports atrial shunting as effective therapy for heart failure patients TEWKSBURY, Mass., June 9, 2022 /PRNewswire/ — Corvia Medical, Inc, a company dedicated to transforming the treatment of heart failure (HF), today announced the closing of a $54 million equity financing from its existing investor syndicate. Funds will be utilized to […]
Nonprofit dedicated to advancing treatment and education for congenital heart defects will award a $5,000 Grant to a deserving hospital-based advanced cardiology fellow Hollis, NH (December 13, 2021) – Heartfelt Dreams Foundation, a nonprofit organization dedicated to enhancing the treatment experience for congenital heart defect (CHD) patients and their families […]
– New results demonstrate MitraClip™ transcatheter edge-to-edge repair (TEER) is effective at treating leaky valves in people with secondary mitral regurgitation (MR) – Data from the first report on patients with a pacemaker lead across the tricuspid valve show TriClip™ and TriClip G4 TEER systems significantly reduce tricuspid regurgitation (TR) […]
MLS-101 is a Highly Selective Aldosterone Synthase Inhibitor Designed to Address Abnormally Elevated Aldosterone, an Underlying Cause of Hypertension Prevalent in a Significant Portion of Patients Derek DiRocco of RA Capital Management and Olivier Litzka, PhD of Andera Partners Join Mineralys Board of Directors PHILADELPHIA, June 8, 2022 /PRNewswire/ — Mineralys Therapeutics, Inc., a private, […]
CRACOW, Poland, June 8, 2022 /PRNewswire/ — The AI-based system developed by Cardiomatics streamlines the work of cardiologists by supporting ECG interpretation. Now, the doctors at PZU Zdrowie (a Polish healthcare provider associated with PZU Group – one of the top insurance companies in East-Central Europe) will be able to take advantage of its […]
— Data indicate HAV does not stimulate increase in panel reactive antibodies, an adaptive immune response correlated with increased risk of implant failure — — Data presented today in IMPACT session at American Transplant Congress (ATC) 2022 — DURHAM, N.C., June 08, 2022 (GLOBE NEWSWIRE) — Humacyte, Inc. (Nasdaq: HUMA), […]
WASHINGTON–(BUSINESS WIRE)–CorVista Health, Inc., a digital health company dedicated to improving cardiovascular disease diagnosis, announces the expansion of their Medical Advisory Board with the appointment of Drs. Vallerie V. McLaughlin and Mark G. Rabbat. The expansion of the Medical Advisory Board reflects the company’s focus on pulmonary hypertension, coronary artery disease […]
ALISO VIEJO, Calif., June 7, 2022 /PRNewswire/ — Okami Medical Inc., a medical device company focused on developing innovative solutions that address key unmet clinical needs in peripheral vascular intervention, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the LOBO-7 and LOBO-9 Vascular Occluders, the latest addition to the […]
